Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
Donor Lymphocyte Infusion for MDS and AML
Recruiting1 awardPhase 1 & 2
Tampa, Florida
This trial is testing the safety of an investigational treatment for myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) after initial therapy has failed. The FDA is funding this study.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.